Cell and gene therapies can be life-changing for patients with certain conditions, but the process of receiving them poses barriers for patients and caregivers that require multistakeholder solutions, ...

The pharmaceutical landscape is undergoing a dramatic transformation. New modalities are reshaping what's possible in drug development, from monoclonal antibodies to RNA therapies, from small ...

Achieving Universal Health Coverage in Bangladesh continues to be hindered by the significant burden of out-of-pocket ...

Exploring sustainable blister packaging from the lens of material selection, quality regulations, machinability, and ...

Payouts to shareholders of large publicly traded health companies more than tripled over the past two decades, new research ...

Lisa Quarrell has been campaigning tirelessly for six years to have her youngest son’s lifesaving medical cannabis prescribed ...

The grants have been the source of new treatments for cancer, heart disease, diabetes, strokes and H.I.V.; wonder drugs like ...

Insilico Medicine pulls back the curtain on developmental timelines, highlighting a ~13 month average timeline to reach developmental candidate (DC) nomination across 22 programs. Insilico’s QPCTL ...

Trump is now in the Oval Office signing executive actions, including a proclamation announcing a 25% tariff on aluminium and steel. "Today I'm simplifying our tariffs on steel and aluminium," Trump ...

The Dispensing Doctors Association, in conjunction with PCC, has published a briefing paper for Pharmaceutical Needs Assessments (PNAs) In England.